The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

“Adjuvant” cancer treatment refers to any therapy you receive ... Examples include: Nausea, headache, fatigue, joint pain, diarrhea, or fever for targeted therapy (targets specific cancer ...

on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) and manufactured by biotech company ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...

Adjuvant endocrine therapy (AET) is a crucial treatment for women with hormone ... identifying common side effects such as pain, fatigue, and mood changes as significant barriers to persistence ...

Adjuvant, intravesical bacillus Calmette–Guérin (BCG) therapy reduces the risk of recurrence and progression of superficial bladder cancer, but confers a considerable risk of local and systemic ...